News

Our latest news, updates and press releases.

News

Our latest news, updates and press releases.

Kaleido to fully launch for adults in the Netherlands

Following a successful pilot scheme at a small selection Dutch hospitals, Kaleido has now fully launched in the Netherlands. As the company behind the smallest and lightest insulin pump in the world, at ViCentra we’re proud to announce that our first Kaleidoers...

read more

Kaleido wins at the Transform Awards Europe 2017!

ViCentra is delighted to announce that Kaleido – our hotly-anticipated new insulin delivery system – was awarded Bronze in the category ‘Best visual identity from the healthcare and pharmaceutical sector’ at last week’s eighth annual Transform Awards Europe....

read more

ViCentra announces new Chairman of the Board

Leading late-stage startup ViCentra, a company focused on the development, manufacture and commercialisation of Kaleido, the insulin pump designed to help people with diabetes live life on their own terms, has today announced the appointment of Jan Keltjens to the...

read more

ViCentra appoints two new medical and scientific advisors

ViCentra, manufacturer of the Kaleido insulin delivery system, today announced the appointment of Dr. David Kerr and Dr. Fred Storms as medical and scientific advisors to its team. Drs. Kerr and Storms are both internationally recognised experts in the treatment of...

read more

Remmert Laan joins ViCentra’s Board

ViCentra today announced that Remmert Laan, President of specialist diabetes consultancy, Diabetes Insights, LLC, has joined the ViCentra Board as a Non-executive Board Member. Prior to launching Diabetes Insights, LLC in 2015, Rem held the position of Executive...

read more

ViCentra Board announce change in management

In anticipation of the imminent commercialisation of the Kaleido insulin delivery system, the ViCentra Board are announcing today a change in management that prepares the Company for the next phase in its future. Joseph Cefai stepped down as CEO on April 1st 2016....

read more

LSP leads financing round in ViCentra

January 16th, 2016. LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in the Series B Round of ViCentra B.V., a private Dutch company commercializing the Kaleido insulin pump system for people with diabetes. The...

read more